Bilirubin levels by hour: when to worry

Quick take: Most newborns develop mild jaundice that peaks around 3–5 days and resolves on its own, but bilirubin levels that rise above the phototherapy threshold (about 15 mg/dL for a term infant at 72 hours) require prompt medical care. Watch for dark yellow skin, a baby’s lethargy, or feeding problems—these are signs to call your provider right away.

It’s 2 a.m., you’ve just finished a feeding, and you notice your baby’s skin looks a little yellower than usual. Your heart races as you wonder: “Is this normal, or am I missing something serious?” You’re not alone. Jaundice is one of the most common reasons parents call the pediatrician in the first week, yet the numbers—bilirubin levels by hour—can feel like a secret code.

In this guide we’ll decode that code, walk you through what the numbers mean at each hour of life, explain why bilirubin climbs, and tell you exactly when to seek help. We’ll also cover the tools doctors use, the treatments that work, and the steps you can take at home while your baby recovers. By the end you’ll have a clear roadmap, a realistic sense of what “normal” looks like, and the confidence to act if something feels off.

Whether you’re caring for a full‑term infant, a premature newborn, or a breast‑fed baby who seems to be fighting a stubborn yellow glow, the information below aligns with guidance from the American Academy of Pediatrics (AAP), the UK’s National Institute for Health and Care Excellence (NICE), and the World Health Organization (WHO). Let’s start with the basics.

Understanding bilirubin: types and metabolism in newborns

Bilirubin is a yellow pigment created when red blood cells break down. In adults, the liver quickly converts bilirubin into a water‑soluble form that the body excretes in stool and urine. Newborns, however, have an immature liver and a higher turnover of red blood cells because fetal hemoglobin is replaced by adult hemoglobin in the first weeks of life. This combination creates a surge of “indirect” (unconjugated) bilirubin that circulates in the bloodstream.

Indirect bilirubin is the form that causes the classic yellowing of the skin and eyes. Once the liver matures, enzymes add a sugar molecule, turning it into “direct” (conjugated) bilirubin, which is harmless and easily eliminated. Most cases of neonatal jaundice involve only indirect bilirubin, but a rise in direct bilirubin can signal a blockage or liver disease and warrants immediate evaluation.

Because the newborn’s liver is still learning the ropes, bilirubin often peaks just before the baby’s third day of life, then declines as the liver matures and feeding improves. Understanding this natural timeline helps you differentiate a harmless “physiologic” jaundice from a potentially dangerous rise that needs treatment.

In addition to the liver’s enzyme development, the newborn gut’s bacterial flora plays a role. The bacteria convert bilirubin‑glucuronide into a form that can be re‑absorbed. As the gut becomes colonized with healthy microbes—usually after the first few days—this re‑absorption drops, further aiding the decline of bilirubin levels.

Normal bilirubin levels by hour/age: reference charts and interpretation

Clini

These numbers are averages; individual babies can fall a little above or below without trouble. For preterm infants (<37 weeks) the curves shift lower, and the phototherapy threshold often starts around 10 mg/dL at 48 hours. If your baby was born early, the Newborn Bilirubin Calculator can generate a personalized chart based on gestational age and risk factors.

Notice the “action threshold” column. Once a baby’s bilirubin crosses that line, most pediatric societies recommend starting phototherapy—especially if the baby is showing any signs of poor feeding or lethargy. Below the threshold, most clinicians opt for close monitoring and supportive measures like frequent feeds.

It’s also useful to know that bilirubin peaks at different times depending on the baby’s health. Full‑term, well‑fed infants typically reach their highest level between 60 and 96 hours. Premature or breast‑fed infants may peak a bit later, sometimes up to 120 hours. This is why the “hourly” chart is a moving target rather than a single cut‑off.

Causes and risk factors for neonatal jaundice

Most cases of jaundice are “physiologic,” meaning they stem from normal newborn physiology. The main drivers include:

• Red blood cell turnover: Newborns have more red cells per kilogram than adults, and the breakdown releases bilirubin.
• Immature liver enzymes: The enzyme UDP‑glucuronosyltransferase (UGT1A1) that conjugates bilirubin isn’t fully active until the second week.
• Breast‑feeding dynamics: Inadequate milk intake can increase bilirubin reabsorption from the gut. “Breast‑feeding jaundice” usually appears in the first 3–5 days and improves with better latch or more frequent feeds.
• Blood‑type incompatibility: Conditions like ABO or Rh incompatibility can cause hemolysis, dramatically raising bilirubin.
• Genetic factors: Rare enzyme deficiencies (e.g., G6PD deficiency) can accelerate bilirubin production.

Other contributors include dehydration, infection, and certain medications (e.g., sulfonamides). Premature babies are especially vulnerable because their livers are even less mature and they often have less robust feeding patterns.

Understanding the root cause helps your provider decide whether the jaundice will resolve with simple measures or whether more intensive treatment is needed. For instance, if bilirubin is rising due to breastfeeding issues, improving latch and feeding frequency can make a big difference.

Recent updates from the CDC emphasize that early identification of hemolytic disease—particularly Rh incompatibility—remains crucial because it can push bilirubin levels into dangerous territory within the first 24 hours. Prompt administration of Rh immunoglobulin (RhIg) for at‑risk infants is a standard preventive step in many hospitals.

When to worry: warning signs, symptoms, and thresholds for medical intervention

The most common red flag is a bilirubin level that climbs above the phototherapy threshold for the baby’s age and risk profile. However, you don’t need a lab result to recognize danger. Look for these clinical signs:

• Skin that turns deep yellow or orange, especially on the abdomen and face.
• Yellowing of the whites of the eyes (scleral icterus).
• Lethargy or difficulty waking for feeds.
• Feeding problems: poor latch, refusing to feed, or feeding less than 8–10 times per 24 hours.
• Vomiting, especially green‑ish (bilious) vomiting.
• High‑pitched crying or a suddenly “floppy” tone.

If any of these appear, call your pediatrician or go to the nearest emergency department. The risk is kernicterus—a rare but devastating brain injury caused by unconjugated bilirubin crossing the blood‑brain barrier. Kernicterus can lead to permanent hearing loss, motor problems, and intellectual disability. The good news is that timely phototherapy almost always prevents this outcome.

For term infants, the AAP recommends phototherapy when TSB reaches roughly 15 mg/dL at 72 hours, or lower if the baby is premature, has hemolysis, or shows clinical signs of severe jaundice. Some hospitals use a “high‑risk” curve that triggers treatment at even lower levels. Your provider will explain which curve they follow.

Guidance from the NHS mirrors these thresholds, noting that “any baby with a bilirubin level above the 95th percentile for their age should be evaluated promptly.” This reinforces the principle that the absolute number matters less than where the baby falls on the age‑specific nomogram.

Diagnostic procedures and monitoring bilirubin levels

When you first notice jaundice, the pediatrician will likely order a total serum bilirubin (TSB) test—a small blood draw from the baby’s heel. In many clinics, a transcutaneous bilirubinometer (TcB) provides a quick, non‑invasive estimate by shining a light on the skin. TcB readings correlate well with TSB in the first few days, but a confirmatory blood test is still needed if the reading is near a treatment threshold.

After the initial test, doctors may repeat the measurement every 12–24 hours until the level is trending down. For babies on phototherapy, the lab checks bilirubin before starting treatment, then again after 12–24 hours to gauge response. In most cases, bilirubin drops by about 0.5–1 mg/dL per day once the underlying cause improves, but the exact rate depends on feeding, gestational age, and treatment modality.

In addition to quantitative labs, clinicians assess the baby’s urine and stool color. Dark urine and pale stools can signal impaired bilirubin excretion, prompting closer surveillance. Conversely, yellow, seedy stools usually indicate that bilirubin is being eliminated effectively.

Treatment options: phototherapy, exchange transfusion, and home management strategies

Phototherapy is the first‑line treatment for most newborns with bilirubin above the threshold. The baby lies under blue‑green lights—either in a conventional overhead unit or a portable “bili‑blanket” that wraps around the torso. The light converts bilirubin into water‑soluble isomers that the liver can excrete without conjugation. Most term infants need 12–24 hours of continuous phototherapy to bring levels down to a safe range.

Phototherapy is highly effective, with success rates above 95 % in term infants. The treatment is painless, but babies may become slightly dehydrated because the lights increase fluid loss through the skin. That’s why clinicians encourage frequent feeds or supplemental IV fluids during therapy. The usual side effects—loose stools, a temporary “bronze” skin tint, and mild temperature changes—are harmless and resolve after treatment stops.

Exchange transfusion is reserved for the rare situation where bilirubin rises despite maximal phototherapy, or when levels exceed 25 mg/dL in a term baby (or lower thresholds in preterm infants). The procedure replaces the baby’s blood with donor blood, instantly lowering bilirubin and removing antibodies that might be causing hemolysis. Because it carries risks such as infection, electrolyte imbalance, and blood‑type reactions, it is only performed in specialized neonatal intensive care units (NICUs).

For parents looking to support the baby’s recovery at home, there are safe strategies:

• Frequent feeding: Aim for at least 8–12 feeds per 24 hours. Breast‑fed babies may need to be expressed or supplemented if the latch is poor.
• Skin‑to‑skin contact: Holding the baby against your chest promotes better feeding and stimulates bowel movements, which help eliminate bilirubin.
• Hydration: If the baby is formula‑fed, offer the recommended amount of water‑based formula. For breast‑fed infants, ensure the mother stays well‑hydrated.
• Monitor stool color: Yellow, seedy stools indicate effective bilirubin excretion. Pale or hard stools may signal slower clearance.

These home measures are adjuncts—not replacements—for medical treatment when bilirubin is high. If your provider prescribes phototherapy, they’ll usually arrange a short hospital stay or a home‑based phototherapy device, depending on the baby’s level and your circumstances.

Potential complications of untreated high bilirubin

If bilirubin remains elevated and crosses into the brain, the result is kernicterus. Early signs include poor feeding, high‑pitched crying, and decreased muscle tone. As the condition progresses, the baby may develop a characteristic “floppy” appearance, difficulty moving limbs, and eventually irreversible neurological damage.

Fortunately, kernicterus is exceedingly rare in countries with routine newborn screening and access to phototherapy. The incidence drops to less than 1 case per 100,000 births when treatment guidelines are followed. That statistic underscores the importance of tracking bilirubin levels and acting quickly if they approach treatment thresholds.

Post‑treatment care and follow‑up recommendations

After phototherapy ends, bilirubin typically continues to fall for another 24–48 hours. Your pediatrician will schedule a follow‑up bilirubin check within a few days to confirm the trend. For babies who required exchange transfusion, a longer monitoring period—often a week or more—is advised, with weekly hemoglobin and bilirubin labs.

During the recovery phase, keep the feeding schedule robust and watch for any resurgence of jaundice. Most babies who receive adequate feeds and have an improving stool pattern stay within safe bilirubin levels. If you notice the yellow tint returning or the baby becoming unusually sleepy, contact your provider promptly.

Many hospitals now provide a discharge “bilirubin action plan” that outlines the exact bilirubin level that would trigger a phone call or a return visit. This plan is often based on the same nomogram used in the hospital, giving you a concrete number to watch for rather than relying on vague “looks yellow” cues.

Home monitoring of bilirubin: tools and tips for parents

While most parents rely on the pediatrician’s lab work, there are a few ways to keep an eye on bilirubin at home without invasive testing. Modern transcutaneous bilirubinometers are sometimes available in community health centers or can be borrowed through hospital outreach programs. These devices give a quick reading by placing a sensor on the baby’s forearm or sternum.

If a device is not accessible, you can still track visual cues. Look for a change in the hue of the skin from pale yellow to a deeper amber, especially on the face and abdomen. Keep a simple log of feeding times, diaper output, and any changes you notice in skin color. This log becomes a valuable communication tool at your next appointment.

Some parents wonder whether a home “bilirubin test kit” is safe. The FDA has not approved any over‑the‑counter test strips for newborn bilirubin, and using an unvalidated product could lead to false reassurance or unnecessary alarm. For reliable results, stick with a clinician‑administered TcB or a serum bilirubin test.

Feeding strategies that help lower bilirubin naturally

Feeding is the single most effective way to speed bilirubin clearance. When the gut moves quickly, bilirubin is excreted in the stool rather than reabsorbed. Here are evidence‑based practices:

• Early and frequent feeds: Begin breastfeeding within the first hour after birth if possible. Aim for at least 8–12 nursing sessions in 24 hours, which encourages gut motility.
• Ensure proper latch: A shallow latch can lead to “milk‑sipping,” which leaves the baby hungry and reduces stool output. Lactation consultants can assess and correct latch issues.
• Supplement when needed: If the baby is not gaining weight or stool frequency is low, supplementing with expressed breast milk or formula for a few feeds can reduce bilirubin levels.
• Hydration for formula‑fed infants: Follow the manufacturer’s mixing instructions precisely; overly concentrated formula can actually increase dehydration risk.
• Consider probiotic support: Some small studies suggest that certain probiotics may enhance gut colonization and promote bilirubin excretion, but the evidence is not yet strong enough for routine recommendation (see CDC guidance on probiotic use in infants).

It’s worth noting that “breast‑feeding jaundice” typically resolves once the mother establishes a steady milk supply and the baby feeds effectively. Most pediatricians advise continuing to breast‑feed while addressing latch or supply concerns, rather than switching to formula abruptly.

What to expect after discharge: ongoing monitoring and reassurance

Once your baby is home, the journey doesn’t end. Most discharge plans include a scheduled follow‑up visit within 48–72 hours, during which a repeat bilirubin measurement is taken. If the level has dropped into the low‑risk zone, the pediatrician may clear the baby for routine care.

During this window, continue the feeding and skin‑to‑skin practices that helped lower bilirubin. Keep an eye on any new yellowing, especially after a missed feeding or a bout of illness. It’s also normal for the baby’s skin to appear slightly pink or orange after phototherapy; this “post‑phototherapy discoloration” fades within a day or two.

If you’re traveling or have limited access to a pediatrician, many health systems now offer telehealth check‑ins where parents can share the baby’s recent bilirubin numbers and a photo of the skin tone. This remote reassurance can reduce anxiety and prevent unnecessary trips to the emergency department.

From our medical team: “If your newborn’s bilirubin is trending upward or you’re unsure about the numbers, bring the latest lab results to your next appointment. Early discussion helps the clinician decide whether a brief phototherapy course or simply more frequent feeds is the right approach.”

Myth vs. fact

Myth: “All newborn jaundice is harmless and will go away on its own.”

Fact: While most cases are benign, bilirubin that climbs above the phototherapy threshold or is accompanied by lethargy requires immediate medical attention to prevent kernicterus.

Myth: “Breast‑feeding causes dangerous jaundice.”

Fact: Breast‑feeding can lead to higher bilirubin levels due to slower gut transit, but the solution is often more frequent feeds, not stopping breastfeeding. In most cases, breast‑fed babies recover with supportive care.

Myth: “If the baby looks yellow, the doctor will automatically order a blood test.”

Fact: Doctors may first use a transcutaneous bilirubinometer to estimate levels. A blood test is ordered only if the estimate is near a treatment threshold or if the baby has risk factors.

Key takeaways

• Bilirubin peaks between 60–96 hours for most term infants; monitor levels closely during the first week.
• Phototherapy is the standard treatment once bilirubin exceeds about 15 mg/dL at 72 hours for a healthy term baby.
• Watch for dark yellow skin, lethargy, poor feeding, or yellowing of the eyes—these are signs to call your provider.
• Frequent feeds, skin‑to‑skin contact, and monitoring stool color help lower bilirubin naturally.
• Premature babies have lower treatment thresholds; use a personalized calculator or ask your clinician for a prematurity‑specific nomogram.
• After treatment, schedule a follow‑up bilirubin check within 48 hours to ensure levels continue to fall.
• Home monitoring tools (TcB) and a feeding log can help you stay ahead of any rising trend.

Frequently asked questions

What is a concerning bilirubin level for a newborn?

A bilirubin level that exceeds the phototherapy threshold for the baby’s age—roughly 15 mg/dL at 72 hours for a term infant—is considered concerning and usually warrants treatment.

How quickly should bilirubin levels drop?

With effective phototherapy, bilirubin typically falls by 0.5–1 mg/dL per day. In babies managed with feeding alone, levels often decrease by 0.2–0.5 mg/dL daily once the underlying cause is addressed.

What are the signs of severe jaundice in a baby?

Severe jaundice may present as deep yellow or orange skin, yellowing of the whites of the eyes, lethargy, poor feeding, high‑pitched crying, and, in rare cases, seizures. Any of these signs require immediate medical evaluation.

Can I treat high bilirubin at home?

Minor elevations can often be managed at home with more frequent feeds, ensuring a good latch, and monitoring stool color. However, bilirubin above the phototherapy threshold should be treated in a medical setting.

What happens if high bilirubin is left untreated?

Untreated high bilirubin can cross the blood‑brain barrier, leading to kernicterus—a serious condition that can cause permanent neurological damage, hearing loss, and motor deficits.

When do doctors recommend phototherapy for jaundice?

Doctors typically recommend phototherapy when bilirubin levels rise above the age‑specific threshold on the AAP nomogram, especially if the baby shows any clinical signs of worsening jaundice.

How often should bilirubin be checked in the first week?

Most hospitals perform a bilirubin screen before discharge (usually at 24 hours) and repeat it at 48–72 hours if the first reading is high or the baby has risk factors. After that, checks are done every 12–24 hours until the level is trending down.

Can certain foods or supplements affect newborn bilirubin?

Maternal diet has little direct impact on a newborn’s bilirubin, but certain infant formulas fortified with high levels of vitamin D or iron can slightly increase bilirubin production. The AAP advises that routine supplementation is safe, but any extra supplements should be discussed with your pediatrician.

When to call your doctor

If you notice any of the following, call your pediatrician or go to the nearest emergency department right away: skin that looks deep yellow or orange, yellowing of the eyes, baby is unusually sleepy or hard to wake, feeds less than 8 times in 24 hours, vomiting, or any sudden change in tone. This information is for educational purposes only and does not replace personalized medical advice.

References

1. American Academy of Pediatrics. “Management of Hyperbilirubinemia in the Newborn Infant 35 or Greater Weeks of Gestation.” Pediatrics, 2022.
2. National Institute for Health and Care Excellence (NICE). “Jaundice in newborns: assessment and early management.” NG203, 2021.
3. World Health Organization. “Guidelines on the Management of Neonatal Jaundice.” WHO, 2020.
4. American College of Obstetricians and Gynecologists. “Committee Opinion No. 757: Neonatal Jaundice.” ACOG, 2020.
5. Mayo Clinic. “Newborn jaundice.” Updated 2023.
6. British Paediatric Association. “Guidelines for the Management of Neonatal Hyperbilirubinemia.” BPA, 2021.
7. US Food and Drug Administration. “Phototherapy Devices for Neonatal Jaundice.” FDA Guidance, 2022.
8. Centers for Disease Control and Prevention. “Neonatal Hemolysis and Jaundice.” CDC, 2021.
9. National Health Service (NHS). “Jaundice in newborn babies.” NHS, 2022.